93 related articles for article (PubMed ID: 15771798)
1. [Results of enhanced ultrasonography in assessing hepatoma treated with radiofrequency ablation].
Yan K; Chen MH; Dai Y; Shen L; Jiang XL
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):41-4. PubMed ID: 15771798
[TBL] [Abstract][Full Text] [Related]
2. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
[TBL] [Abstract][Full Text] [Related]
3. [Imaging evaluation of efficacy of radiofrequency ablation treatment for hepatic cancer].
Zhang ZJ; Wu MC; Liu Q; Chen D
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):616-9. PubMed ID: 16438873
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
5. Four-dimensional ultrasonography for therapeutic radiofrequency ablation for hepatocellular carcinoma.
Hotta N; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Fukuzawa Y; Kakumu S
Hepatogastroenterology; 2006; 53(70):521-5. PubMed ID: 16995453
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
Dill-Macky MJ; Asch M; Burns P; Wilson S
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
[TBL] [Abstract][Full Text] [Related]
7. [Percutaneous radiofrequency ablation with artificial hydrothorax for liver cancer in the hepatic dome].
Han Y; Yu L; Hao YZ; Yang M; Liu S; Deng YB; He LF; Cai JQ; Chen MH
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):846-9. PubMed ID: 23291135
[TBL] [Abstract][Full Text] [Related]
8. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
[TBL] [Abstract][Full Text] [Related]
12. [Application of contrast-enhanced ultrasonography in selecting indication of radiofrequency ablation among hepatocellular carcinoma patients].
Chen MH; Wu W; Yang W; Gao W; Dai Y; Yin SS; Huo L; Yan K
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3491-4. PubMed ID: 16686066
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
[TBL] [Abstract][Full Text] [Related]
14. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
15. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
18. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography?
Zhou P; Kudo M; Minami Y; Chung H; Inoue T; Fukunaga T; Maekawa K
Oncology; 2007; 72 Suppl 1():92-7. PubMed ID: 18087188
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation guided by contrast-enhanced ultrasound for hepatic malignancies: preliminary results.
Dong Y; Wang WP; Gan YH; Huang BJ; Ding H
Clin Radiol; 2014 Nov; 69(11):1129-35. PubMed ID: 25060936
[TBL] [Abstract][Full Text] [Related]
20. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system.
Hiraoka A; Hirooka M; Koizumi Y; Hidaka S; Uehara T; Ichikawa S; Hasebe A; Miyamoto Y; Ninomiya T; Michitaka K; Horiike N; Yamashita Y; Hiasa Y; Matsuura B; Onji M
Oncol Rep; 2010 Feb; 23(2):493-7. PubMed ID: 20043112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
